MGH and Mount Sinai team up

Diseases of the tricuspid lack minimally-invasive options

An increase of 286,000 over the previous year

Every patient, and every device is different

Better predictive modeling helps tailor specific post-transplant care to each patient

The election, wearables and mergers will be top of mind for device makers this year

Planning the foundation of a scalable and decentralized data sharing ecosystem

Danish study renews debate over value of early detection

How the ACA has been vital to rural care facilities

They say low dose radiation 'likely helps prevent' cancer

New evidence that density should impact screening decisions

57 percent reduction in infection rate

Accelerating genomic insights through select collaborations

Acquisition will complement Welch Allyn business

Update addresses hacker vulnerabilities

Tool developed by imaging policy group helps rads manage MIPS impact

Researchers point to a future without pacemaker battery replacements

Government group weighs in on 'advancing high-value imaging'

Cybersecurity concerns and physician disinterest needs to be addressed

More research needed for FDA approval

A look at Rep. Tom Price's advocacy track record

Goal is to cut down on operating losses and save about $120 million

Jury award reduced from $1 billion to $500 million

Quality of care wasn't compromised

Drastic reductions in prostate, breast, lung and colorectal cancer mortality

The same thing that gives them their bite may also inhibit breast cancer growth

NIH awards $5 million grant

Patient-specific model mimics physiology of artificial valve pressure response

Patient a day late for appointment tips off researchers

Creating a smaller, more affordable proton solution

Has the potential to prevent vision loss

Alleges company violated antitrust regulations

But a trend toward patient access to reports and face time is emerging

Appoints new CEO of McKesson Canada

Combined portfolio expected to hit $8.7 billion in sales annually

Breast cancer targeting probes are showing promise in clinical trials

Possible flaw in reimbursement model outlined

'Annual screening of women over 40 is the way to save the most lives'

Shares have fallen 40 percent since Tuesday

Noninvasive technology examines tau proteins